Experimental Study on the Public Display of Lists of Harmful and Potential Harmful Tobacco Constituents

ICR 201301-0910-004

OMB: 0910-0736

Federal Form Document

Forms and Documents
Document
Name
Status
Supporting Statement B
2013-01-15
Supplementary Document
2013-01-15
Supplementary Document
2013-01-15
Supplementary Document
2013-01-15
Supplementary Document
2013-01-15
Supporting Statement A
2013-01-15
IC Document Collections
IC ID
Document
Title
Status
202182 Modified
202181 Modified
202180 Modified
ICR Details
0910-0736 201301-0910-004
Historical Active 201205-0910-004
HHS/FDA
Experimental Study on the Public Display of Lists of Harmful and Potential Harmful Tobacco Constituents
New collection (Request for a new OMB Control Number)   No
Regular
Approved without change 03/22/2013
Retrieve Notice of Action (NOA) 01/17/2013
  Inventory as of this Action Requested Previously Approved
03/31/2016 36 Months From Approved
13,210 0 0
1,772 0 0
0 0 0

The purpose of this submission is to request OMB approval to conduct an experimental study to help inform FDA decisions about how to implement section 904(d)(1) of the Food Drug & Cosmetic Act (FD&C Act or the Act) and to provide information about how consumers understand information about Harmful and Potentially Harmful Constituents (HPHCs) in tobacco products.

PL: Pub.L. 111 - 31 1 Name of Law: Family Smoking Prevention and Tobacco Control Act
  
None

Not associated with rulemaking

  76 FR 77837 12/14/2011
77 FR 26284 05/03/2012
Yes

3
IC Title Form No. Form Name
Pre Test
Screener
Experimental Survey

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 13,210 0 0 13,210 0 0
Annual Time Burden (Hours) 1,772 0 0 1,772 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
This is a new information collection.

$302,949
Yes Part B of Supporting Statement
No
No
No
No
Uncollected
Daniel Gitteson 3017965156 daniel.gitteson@fda.hhs.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
01/17/2013


© 2024 OMB.report | Privacy Policy